Epitalon is the peptide people mean when they say “telomeres.” It is sold as an anti-aging compound that lengthens the protective caps on your chromosomes and resets your body clock. Those claims trace back mostly to one research group in Russia. In July 2026, an FDA advisory panel recommended it for compounding, but only for insomnia, and against the advice of FDA’s own staff. Here is the honest picture.
Thin and concentrated. Nearly all the animal and human data comes from one research network in St. Petersburg. The FDA’s 2026 review found no clinical studies of epitalon’s safety in humans and no data on how the body processes it. There is one notable independent lab study from 2025 showing telomere lengthening in cells. That is a real finding. It is also a petri dish, not a person.
Epitalon, also spelled Epithalon, is a synthetic peptide of just four amino acids: alanine, glutamic acid, aspartic acid and glycine. It was designed based on epithalamin, an extract taken from cattle pineal glands.
Here is a detail that matters. Epitalon and epithalamin are not the same thing. One is a four-amino-acid synthetic peptide. The other is a gland extract. The FDA pointed this out in its review, and many sellers blur the two. Some of the most famous “lifespan” data was on the extract, not the peptide being sold.
It was developed by Professor Vladimir Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology. Khavinson’s broader theory is that short peptides act as “bioregulators,” switching specific genes on and off in specific tissues. That idea is mostly confined to his own school of research and has not been accepted by mainstream pharmacology. Epitalon once had a US orphan drug designation for an eye disease, granted in 2010. That designation was later withdrawn.
Three main claims, with very different levels of support.
Telomeres. Telomeres are the caps on the ends of your chromosomes. They shorten as cells divide, and short telomeres are linked to aging. An enzyme called telomerase can rebuild them. A 2003 Khavinson study reported that epitalon switched on telomerase and lengthened telomeres in human cells in culture. In 2025, a team at Brunel University London independently saw dose-dependent telomere lengthening in normal cells. That is the strongest piece of evidence. It is still cells only.
Melatonin. In old monkeys, epitalon raised evening melatonin more than four-fold. A small human study in women with low melatonin found a rise in a melatonin marker. But it was short, small, and did not measure sleep at all.
Gene regulation. This rests almost entirely on Khavinson-affiliated papers.
In mice, Khavinson’s and Anisimov’s studies reported longer lifespan and fewer tumors. The FDA’s critique was pointed. Each study used one dose, only female mice, and short bursts of exposure. None was a standard long-term cancer study.
The most-cited human study, from 2003, followed 266 elderly people for six to eight years and reported lower death rates. But the people in that study were given epithalamin, the gland extract, not synthetic epitalon. Treatment assignment was unclear. It came from the same group. And it has never been replicated.
So when you read “proven to extend human lifespan,” know that it is not true.
Anti-aging, telomere support, sleep, melatonin, skin and general longevity. The FDA documented clinic websites making these claims. None has been proven in people.
The big one is cancer, and it is a real theoretical concern, not a scare tactic. Cancer cells use telomerase to keep dividing forever. Something that switches telomerase on could, in principle, help a cell escape the normal limits on aging and division. The FDA said directly that epitalon “has the potential to be carcinogenic” based on its mechanism. The 2025 Brunel study added a wrinkle: in breast cancer cell lines, epitalon lengthened telomeres through a separate pathway that cancer cells are known to use.
Beyond that, there are no long-term studies, no adequate genetic-damage testing, and no data on how the body handles it. The FDA also found inconsistent paperwork from suppliers on identity and purity.
Reporting, not a recommendation. Community sources describe 5 to 10 mg a day by injection under the skin, or oral forms, usually in short cycles repeated a few times a year. No human study has established any dose. We do not give mixing or injection steps.
Not FDA-approved, and not approved in the EU, UK, Canada or Australia either. In 2023 the FDA placed epitalon in Category 2, which blocked compounding. It was removed from Category 2 in April 2026 after the nominations were withdrawn. That did not make it legal. It just set up a fresh review.
At the July 2026 Pharmacy Compounding Advisory Committee meeting, the FDA reviewed epitalon for insomnia only. FDA staff recommended against it, citing no evidence it works for insomnia, poor characterization, and the cancer concern. The panel voted to recommend it anyway, with seven in favor and one abstention. That vote is not binding. The FDA still has to go through formal rulemaking, which could run into 2027 or later. We cover that process in our post on the “Do Not Compound” list.
Epitalon is not named on the WADA list, but it likely falls under the “non-approved substances” category, which is banned at all times. Athletes should treat it as prohibited.
Is epitalon FDA-approved? No. An advisory panel recommended it for compounding in July 2026, for insomnia only, but that is not approval and not final.
Does it lengthen telomeres? In cell cultures, yes, including one independent 2025 study. Not shown in humans.
Does it extend human lifespan? Unproven. The famous mortality data used the gland extract, came from one group, and has not been replicated.
Does it help sleep? No study has measured sleep. There is limited data on melatonin markers only.
Can it cause cancer? Unknown. The FDA flagged a real mechanistic concern, and the mouse studies are too limited to settle it.
Is epitalon the same as epithalamin? No. One is a synthetic four-amino-acid peptide. The other is a pineal gland extract.
Is it banned in sport? Probably, under WADA’s non-approved substances category.
Plain-language updates on new research and the shifting rules. No hype, unsubscribe anytime.